ALİ GÜREL, İrem Pembegül YİĞİT, Hülya TAŞKAPAN, Emine ŞAMDANCI, Lokman Hekim TANRİVERDİ

A patient with primary hyperoxaluria who developed excessive pericardial effusion despite intensive dialysis

Primary hyperoxaluria type 1 (PH type 1) is a hereditary disorder with excessive production of oxalate caused by deficient liver specific enzyme alanineglyoxylate aminotransferase (AGT). Increased oxalate production leads to calcium oxalate deposition in different organs and tissues, such as kidney, heart, nervous system, skin, bone and bone marrow. Early diagnosis is essential to prevent complications. Family history, urine oxalate assesment, oxalaemia, determination of oxalate deposits in tissues and genetic analysis are beneficial for diagnosis. Treatment should be started at early stages of the disease in order to decrease urinary saturation of calcium oxalate. High fluid intake, urinary crystallisation inhibitors and pyridoxine may be used. In chronic kidney failure patients renal replacement therapies are necessary, early transplantation is mandatory. We present a 30 year old man with PH type 1 who admitted with severe pericardial effusion, despite the fact that he was maintained both peritoneal dialysis and frequent hemodialysis.

Tam Metin

Kaynakça

Lorenzo V, Torres A, Salido E. Primary hyperoxaluria. Nefrologia. 2014;34(3):398-412.

Hoppe B. An update on primary hyperoxaluria. Nat Rev Nephrol. 2012;8(8):467-75.

Tang X, Bergstralh EJ, Mehta RA, Vrtiska TJ, Milliner DS, Lieske JC. Nephrocalcinosis is a risk factor for CKF in PH. Kidney Int. 2015; 87(3):623-31.

Lieske JC, Monico CG, Holmes WS, Bergstralh EJ, Slezak JM, Rohlinger AL, Olson JB, Milliner DS. International registry for primary hyperoxaluria. Am J Nephrol. 2005;25(3):290-6.

Cochat P, Fargue S, Bacchetta J, Bertholet-Thomas A, Sabot JF, Harambat J. Primary hyperoxaluria. Nephrol Ther. 2011;7(4):249-59.

Lorenz EC, Michet CJ, Milliner DS, Lieske JC. Update on oxalate crystal disease. Curr Rheumatol Rep. 2013;15(7):340-53.

Hoppe B, Kemper MJ, Bokenkamp A, Portale AA, Cohn RA, Langman CB. Plasma calcium oxalate supersaturation in children with primary hyperoxaluria and end-stage renal failure. Kidney Int. 1999;56(1):268-74.

Julian BA, Faugere MC, Malluche HH. Oxalosis in bone causing a radiographical mimicry of renal osteodystrophy. Am J Kidney Dis. 1987;9(5):436-40.

Palka P, Duhig E, Carey L, Galbraith A. Primary oxalosis with cardiac involvement: Echocardiographic features of an unusual form of cardiomyopathy. Circulation. 2001;103(24):122-3.

Cochat P, Hulton SA, Acquaviva C, Danpure CJ, Daudon M, De Marchi M, Fargue S, Groothoff J, Harambat J, Hoppe B, Jamieson NV, Kemper MJ, Mandrile G,Marangella M, Picca S, Rumsby G, Salido E, Straub M, van Woerden CS; OxalEurope. Primary hyperoxaluria Type 1:indications for screening and guidance for diagnosis and treatment. Nephrol Dial Transplant. 2012;27(5):1729- 36.

Van Driessche L, Dhondt A, De Sutter J. Heart failure with mitral valve regurgitation due to primary hyperoxaluria type 1: Case report with review of the literature. Acta Cardiol. 2007;62(2):202-6.

Milliner DS. The primary hyperoxalurias: an algorithm for diagnosis. Am J Nephrol. 2005;25(2):154-60.

Marangella M, Petrarulo M, Mandolfo S, Vitale C, Cosseddu D, Linari F. Plasma Profiles and dialysis kinetics of oxalate in patients receiving hemodialysis. Nephron. 1992;60(1):74-80.

Tang X, Voskoboev NV, Wannarka SL, Oslon JB, Milliner DS, Lieske JC. Oxalate quantification in hemodialysate to assess dialysis adequancy 2014;39(5):376-82. Am J Nephrol.

Millan MT, Berquist WE, So SK, Sarwal MM, Wayman KI, Cox KL, Filler G, Salvatierra O Jr, Esquivel CO. One hundred percent patient and kidney allograft survival with simultaneous liver and kidney transplantation in infants with primary hyperoxaluria: a single center experience. Transplantation. 2003;76(10):1458-63.